![UK High Court finds patent for Metoject® technology invalid on the ground of obviousness - AA Thornton UK High Court finds patent for Metoject® technology invalid on the ground of obviousness - AA Thornton](https://www.aathornton.com/wp-content/uploads/2016/04/iStock_000072544403_Medium.jpg)
UK High Court finds patent for Metoject® technology invalid on the ground of obviousness - AA Thornton
![Otrexup Methotrexate Self Injection Device Receives FDA Approval to Treat Rheumatoid Arthritis | Medgadget Otrexup Methotrexate Self Injection Device Receives FDA Approval to Treat Rheumatoid Arthritis | Medgadget](https://www.medgadget.com/wp-content/uploads/2015/03/2015-03-17-15-41-52-1716520759.jpg)
Otrexup Methotrexate Self Injection Device Receives FDA Approval to Treat Rheumatoid Arthritis | Medgadget
![Philip Gardiner on Twitter: "Coming soon in UK. Single use Metoject injector pen, same price as Methotrexate injection. Easy to use #rheum http://t.co/ht9QQmqBVj" / Twitter Philip Gardiner on Twitter: "Coming soon in UK. Single use Metoject injector pen, same price as Methotrexate injection. Easy to use #rheum http://t.co/ht9QQmqBVj" / Twitter](https://pbs.twimg.com/media/BmlBooqIYAAHWaJ.jpg)
Philip Gardiner on Twitter: "Coming soon in UK. Single use Metoject injector pen, same price as Methotrexate injection. Easy to use #rheum http://t.co/ht9QQmqBVj" / Twitter
![Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis | SpringerLink Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40744-017-0057-3/MediaObjects/40744_2017_57_Fig1_HTML.gif)
Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis | SpringerLink
![LONDON, UK - AUGUST 18, 2019: Pack of Metoject 20mg solution for injection in pre-filled pen on white. Methotrexate – Stock Editorial Photo © DenisMArt #298876998 LONDON, UK - AUGUST 18, 2019: Pack of Metoject 20mg solution for injection in pre-filled pen on white. Methotrexate – Stock Editorial Photo © DenisMArt #298876998](https://st4.depositphotos.com/1010386/29887/i/1600/depositphotos_298876998-stock-photo-london-uk-august-18-2019.jpg)
LONDON, UK - AUGUST 18, 2019: Pack of Metoject 20mg solution for injection in pre-filled pen on white. Methotrexate – Stock Editorial Photo © DenisMArt #298876998
![Otrexup™ Antineoplastic Agent Methotrexate, Preservative Free 15 mg / 0.4 mL Subcutaneous Injection Auto-Injector Pen 4 Devices - Suprememed Otrexup™ Antineoplastic Agent Methotrexate, Preservative Free 15 mg / 0.4 mL Subcutaneous Injection Auto-Injector Pen 4 Devices - Suprememed](https://www.suprememed.com/wp-content/uploads/2022/02/54436001504.jpg)